Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Cheryl, Meguid"'
Autor:
Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A. Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-Chanza, Tracy L. Rose, Lauren C. Harshman, Dharmesh Gopalakrishnan, Ulka Vaishampayan, Yousef Zakharia, Vivek Narayan, Benedito A. Carneiro, Anthony Mega, Nirmish Singla, Cheryl Meguid, Saby George, James Brugarolas, Neeraj Agarwal, Amir Mortazavi, Sumanta Pal, Rana R. McKay, Elaine T. Lam
Publikováno v:
EClinicalMedicine, Vol 60, Iss , Pp 102018- (2023)
Summary: Background: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic metastases are uncommon overall, wi
Externí odkaz:
https://doaj.org/article/153c01ff313644d0bf2fd30f76560d5d
Autor:
Kristen Oase, MS, PA-C, Cheryl Meguid, DNP, ACNP, Atsushi Oba, Mohammed H. Al-Musawi, MD, MSc, FIBMS-CTV, FRCS (Glasg), Alison Sheridan, MD, Evan Norris, MD, Sanjana Mehrotra, MD, Mark A. Lovell, MD, Richard D. Schulick, MD, MBA, FACS, Steven A. Ahrendt, MD, Marco Del Chiaro, MD, PhD, FACS
Publikováno v:
Journal of the advanced practitioner in oncology. 13(5)
Purpose: Solid pseudopapillary neoplasms (SPN) are rare pancreatic cystic neoplasms with low malignant potential that tend to occur in young women. Due to the rarity of this disease, there are few large case series in the literature, and the exact pa
Autor:
E S Wooten, Cheryl Meguid, Gentry Teng King, Tracey E. Schefter, Stephen Leong, Karyn A. Goodman, Tom Purcell, Alexis D. Leal, Yuki Fujiwara, Christopher H. Lieu, Ana Gleisner, S.L. Davis, Laurel Beaty, Steven S. Ahrendt, M Del Chiaro, Sana D. Karam, Y H A Wu, Kathryn L. Colborn, Wells A. Messersmith, Richard D. Schulick, Mohammed Al-Musawi, Atsushi Oba
Publikováno v:
British Journal of Surgery. 108:976-982
Background Use of neoadjuvant therapy for elderly patients with pancreatic cancer has been debatable. With FOLFIRINOX (folinic acid, 5-fluorouracil, irinotecan, oxaliplatin) or gemcitabine plus nab-paclitaxel (GnP) showing tremendous effects in impro
Autor:
Ioannis A. Ziogas, Salvador Rodriguez Franco, Nicholas Schmoke, Cheryl Meguid, Cassandra Murphy, Mohammed Al-Musawi, Sophoclis P. Alexopoulos, Richard D. Schulick, Marco Del Chiaro
Publikováno v:
Cancers. 15:1185
Background: Current evidence on overall survival (OS) between invasive pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm (IPMN) is limited to single-center reports. We aimed to compare the characteristics, management
Autor:
Patrick Hosokawa, Mohammed Al-Musawi, Steven S. Ahrendt, Marco Del Chiaro, Atsushi Oba, Richard D. Schulick, Ana Gleisner, C Croce, Robert J. Torphy, Cheryl Meguid
Publikováno v:
Annals of Surgery. 275:175-181
Objective To identify objective preoperative prognostic factors that are able to predict long-term survival of patients affected by PDAC. Summary of background data In the modern era of improved systemic chemotherapy for PDAC, tumor biology, and resp
Autor:
Atsushi Oba, Y H Andrew Wu, Kathryn L Colborn, Sana D Karam, Cheryl Meguid, Mohammed H Al-Musawi, Quoc R Bao, Ana L Gleisner, Steven Ahrendt, Richard D Schulick, Marco Del Chiaro
Background Neoadjuvant treatment is important for improving the rate of R0 surgical resection and overall survival outcome in treating patients with pancreatic ductal adenocarcinoma (PDAC). However, the true efficacy of radiotherapy (RT) for neoadjuv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4ad1bbea5b7cc4ecb9489172d8ba5f
https://hdl.handle.net/11577/3474097
https://hdl.handle.net/11577/3474097
Autor:
Joseph M. Herman, Carrie Tompkins Stricker, Sarah Myers, Bobby Korah, Amol Narang, Amy Hacker-Prietz, Danielle Deperalta, Theodore S. Hong, Amy Dullard, Andrew Lowy, Aslam Ejaz, Margaret A. Tempero, George A. Fisher, Andrew L. Coveler, Daniel King, Danielle Pinto, Cheryl Meguid, Todd Anthony Aguilera, William Arthur Hoos, Peter Margolis
Publikováno v:
Journal of Clinical Oncology. 40:368-368
368 Background: Pancreas cancer (PC) survival is among the lowest of all malignancies. While limited advances in treatment are a major driver of this reality, ample opportunity exists to improve outcomes by reducing care variation, providingcoordinat
Autor:
Cheryl Meguid, Miles Piper, James C. Costello, Michael J. Gough, Adam C. Mueller, Michael W. Knitz, Shilpa Bhatia, Adrie van Bokhoven, Kimberly R. Jordan, Antonio Galvao Neto, Richard D. Schulick, S.J. Zakem, Benjamin Van Court, Jason S. Williams, Martin D. McCarter, Thomas E. Bickett, Marco Del Chiaro, Kirk C. Hansen, Casey S. Greene, Brisa Peña, Shiv Bhuvane, Sana D. Karam, David Lagares, Ayman Oweida, Luisa Mestroni, Kathryn L. Zolman, Wells A. Messersmith, Peter J. Dempsey, Andrew Goodspeed, M. Scott Lucia, Matthew R.G. Taylor, Jacob Gadwa, Laurel B. Darragh, Karyn A. Goodman, Andy Phan
Publikováno v:
Cancer Res
Stromal fibrosis activates prosurvival and proepithelial-to-mesenchymal transition (EMT) pathways in pancreatic ductal adenocarcinoma (PDAC). In patient tumors treated with neoadjuvant stereotactic body radiation therapy (SBRT), we found upregulation
Autor:
Richard D. Schulick, Ronggui Lin, Cheryl Meguid, Atsushi Oba, Marco Del Chiaro, Y. H. Andrew Wu, Shuichi Watanabe
Publikováno v:
J Gastrointest Oncol
Pancreatic cancer (PC) is likely to become the second leading cause of malignancy-associated mortality within the next 10 years and surgery remains the best hope for cure. The introduction of effective neoadjuvant treatment (NAT) has increased the re
Autor:
Sarah Lindsey Davis, Swati G. Patel, Amy Walde, William T. Purcell, Patrick J. Blatchford, Rebekah Anders, Megan D. Marsh, Cheryl Meguid, Christopher H. Lieu, Steven A. Ahrendt, Elisa H. Birnbaum, Gurprataap S. Sandhu, Stephen Leong, Wells A. Messersmith, Karyn A. Goodman, Ana Gleisner, Richard D. Schulick, Jon D. Vogel, Gentry Teng King, Tracey E. Schefter, Reed Weiss, Matthew A. Brown, Alexis D. Leal, Michelle L. Cowan, Marco Del Chiaro, Whitney Herter, Martin D. McCarter
Publikováno v:
Colorectal Cancer. 9
Background: We examined characteristics of early-onset colorectal cancer (CRC) patients to identified factors, which may lead to earlier diagnosis. Materials & methods: This is a retrospective study with inclusion criteria: CRC diagnosed between 2012